| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.8M | +26.7% |
| Cost of Revenue | $3.5M | -30.8% |
| R&D Expense | $10.4M | -73.2% |
| SG&A Expense | $16.8M | -46.5% |
| Operating Income | -$26.9M | +77.7% |
| Pre-tax Income | -$72.6M | +37.2% |
| Income Tax | $5K | -28.6% |
| Net Income | -$72.6M | +37.2% |
| EPS (Basic) | -$2.71 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.2M | +34.8% |
| Short-term Investments | $8.9M | -44.3% |
| Accounts Receivable | $134K | -75.9% |
| Inventory | $71K | -93.3% |
| Current Assets | $42.7M | -5.2% |
| Total Assets | $56.3M | -6.9% |
| Current Liabilities | $4.4M | -47.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.6M | +70.5% |
| Capital Expenditures | $265K | -66.1% |
| Investing Cash Flow | $6.9M | -89.4% |
| Financing Cash Flow | $23.8M | — |
| Free Cash Flow | -$22.9M | +70.4% |
| +39.9% |
| EPS (Diluted) | -$2.71 | +39.9% |
| Total Liabilities |
| $65.8M |
| +237.0% |
| Stockholders' Equity | -$9.5M | -123.3% |